OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The increase in serum uric acid concentration caused by diuretics might be beneficial in heart failure
Ariel J. Reyes
European Journal of Heart Failure (2005) Vol. 7, Iss. 4, pp. 461-467
Open Access | Times Cited: 58
Ariel J. Reyes
European Journal of Heart Failure (2005) Vol. 7, Iss. 4, pp. 461-467
Open Access | Times Cited: 58
Showing 1-25 of 58 citing articles:
Endogenous non-enzymatic antioxidants in the human body
Iwona Mirończuk-Chodakowska, Anna Maria Witkowska, Małgorzata Elżbieta Zujko
Advances in Medical Sciences (2017) Vol. 63, Iss. 1, pp. 68-78
Closed Access | Times Cited: 510
Iwona Mirończuk-Chodakowska, Anna Maria Witkowska, Małgorzata Elżbieta Zujko
Advances in Medical Sciences (2017) Vol. 63, Iss. 1, pp. 68-78
Closed Access | Times Cited: 510
RONS and Oxidative Stress: An Overview of Basic Concepts
Ana Karina Aranda‐Rivera, Alfredo Cruz‐Gregorio, Yalith Lyzet Arancibia‐Hernández, et al.
Oxygen (2022) Vol. 2, Iss. 4, pp. 437-478
Open Access | Times Cited: 177
Ana Karina Aranda‐Rivera, Alfredo Cruz‐Gregorio, Yalith Lyzet Arancibia‐Hernández, et al.
Oxygen (2022) Vol. 2, Iss. 4, pp. 437-478
Open Access | Times Cited: 177
Uric Acid and Cardiovascular Disease: An Update
María Lorenza Muiesan, Claudia Agabiti-Rosei, Anna Paini, et al.
European Cardiology Review (2016) Vol. 11, Iss. 1, pp. 54-54
Open Access | Times Cited: 109
María Lorenza Muiesan, Claudia Agabiti-Rosei, Anna Paini, et al.
European Cardiology Review (2016) Vol. 11, Iss. 1, pp. 54-54
Open Access | Times Cited: 109
Hyperuricemia and Incident Heart Failure
Eswar Krishnan
Circulation Heart Failure (2009) Vol. 2, Iss. 6, pp. 556-562
Open Access | Times Cited: 117
Eswar Krishnan
Circulation Heart Failure (2009) Vol. 2, Iss. 6, pp. 556-562
Open Access | Times Cited: 117
Serum uric acid and the risk of hypertension and chronic kidney disease
Daniel I. Feig
Current Opinion in Rheumatology (2014) Vol. 26, Iss. 2, pp. 176-185
Closed Access | Times Cited: 95
Daniel I. Feig
Current Opinion in Rheumatology (2014) Vol. 26, Iss. 2, pp. 176-185
Closed Access | Times Cited: 95
The Role of Uric Acid in the Pathogenesis of Hypertension in the Young
Daniel I. Feig
Journal of Clinical Hypertension (2012) Vol. 14, Iss. 6, pp. 346-352
Open Access | Times Cited: 85
Daniel I. Feig
Journal of Clinical Hypertension (2012) Vol. 14, Iss. 6, pp. 346-352
Open Access | Times Cited: 85
Uric acid and cardiometabolic diseases
Seung Jae Lee, Byeong Kil Oh, Ki‐Chul Sung
Clinical Hypertension (2020) Vol. 26, Iss. 1
Open Access | Times Cited: 57
Seung Jae Lee, Byeong Kil Oh, Ki‐Chul Sung
Clinical Hypertension (2020) Vol. 26, Iss. 1
Open Access | Times Cited: 57
Hyperuricemia and Hypertension
Daniel I. Feig
Advances in Chronic Kidney Disease (2012) Vol. 19, Iss. 6, pp. 377-385
Open Access | Times Cited: 68
Daniel I. Feig
Advances in Chronic Kidney Disease (2012) Vol. 19, Iss. 6, pp. 377-385
Open Access | Times Cited: 68
Uric Acid as a Risk Factor for Cardiovascular Disease and Mortality in Overweight/Obese Individuals
Helle Skak-Nielsen, Christian Torp‐Pedersen, Nick Finer, et al.
PLoS ONE (2013) Vol. 8, Iss. 3, pp. e59121-e59121
Open Access | Times Cited: 67
Helle Skak-Nielsen, Christian Torp‐Pedersen, Nick Finer, et al.
PLoS ONE (2013) Vol. 8, Iss. 3, pp. e59121-e59121
Open Access | Times Cited: 67
Strategies Preventing Contrast-Induced Nephropathy After Coronary Angiography: A Comprehensive Meta-Analysis and Systematic Review of 125 Randomized Controlled Trials
Sadegh Ali‐Hassan‐Sayegh, Seyed Jalil Mirhosseini, Zahra Ghodratipour, et al.
Angiology (2016) Vol. 68, Iss. 5, pp. 389-413
Closed Access | Times Cited: 52
Sadegh Ali‐Hassan‐Sayegh, Seyed Jalil Mirhosseini, Zahra Ghodratipour, et al.
Angiology (2016) Vol. 68, Iss. 5, pp. 389-413
Closed Access | Times Cited: 52
Higher uric acid serum levels are associated with better muscle function in the oldest old: Results from the Mugello Study
Raffaele Molino-Lova, Francesco Sofi, Guido Pasquini, et al.
European Journal of Internal Medicine (2017) Vol. 41, pp. 39-43
Closed Access | Times Cited: 50
Raffaele Molino-Lova, Francesco Sofi, Guido Pasquini, et al.
European Journal of Internal Medicine (2017) Vol. 41, pp. 39-43
Closed Access | Times Cited: 50
Higher circulating levels of uric acid are prospectively associated with better muscle function in older persons
Claudio Macchi, Raffaele Molino-Lova, Paola Polcaro, et al.
Mechanisms of Ageing and Development (2008) Vol. 129, Iss. 9, pp. 522-527
Open Access | Times Cited: 63
Claudio Macchi, Raffaele Molino-Lova, Paola Polcaro, et al.
Mechanisms of Ageing and Development (2008) Vol. 129, Iss. 9, pp. 522-527
Open Access | Times Cited: 63
Uric Acid and Hypertension
Daniel I. Feig
Seminars in Nephrology (2011) Vol. 31, Iss. 5, pp. 441-446
Closed Access | Times Cited: 56
Daniel I. Feig
Seminars in Nephrology (2011) Vol. 31, Iss. 5, pp. 441-446
Closed Access | Times Cited: 56
Uric acid is a biomarker for heart failure, but not therapeutic target: result from a comprehensive meta‐analysis
Shiwei Qin, Meilin Xiang, Lei Gao, et al.
ESC Heart Failure (2023) Vol. 11, Iss. 1, pp. 78-90
Open Access | Times Cited: 13
Shiwei Qin, Meilin Xiang, Lei Gao, et al.
ESC Heart Failure (2023) Vol. 11, Iss. 1, pp. 78-90
Open Access | Times Cited: 13
Uric acid in heart failure: a biomarker or therapeutic target?
Marc Kaufman, Maya Guglin
Heart Failure Reviews (2012) Vol. 18, Iss. 2, pp. 177-186
Closed Access | Times Cited: 45
Marc Kaufman, Maya Guglin
Heart Failure Reviews (2012) Vol. 18, Iss. 2, pp. 177-186
Closed Access | Times Cited: 45
Xanthine oxidase inhibition for the treatment of cardiovascular disease: an updated systematic review and meta‐analysis
Jufen Zhang, Riet Dierckx, Kevin Mohee, et al.
ESC Heart Failure (2016) Vol. 4, Iss. 1, pp. 40-45
Open Access | Times Cited: 28
Jufen Zhang, Riet Dierckx, Kevin Mohee, et al.
ESC Heart Failure (2016) Vol. 4, Iss. 1, pp. 40-45
Open Access | Times Cited: 28
Targeting Xanthine Oxidase by Natural Products as a Therapeutic Approach for Mental Disorders
Miquel Martorell, Xavier Lucas, Pedro Alarcón, et al.
Current Pharmaceutical Design (2020) Vol. 27, Iss. 3, pp. 367-382
Closed Access | Times Cited: 25
Miquel Martorell, Xavier Lucas, Pedro Alarcón, et al.
Current Pharmaceutical Design (2020) Vol. 27, Iss. 3, pp. 367-382
Closed Access | Times Cited: 25
Serum uric acid correlates with extracellular superoxide dismutase activity in patients with chronic heart failure
Hernán Alcaíno, Douglas Greig, Mario Chiong, et al.
European Journal of Heart Failure (2008) Vol. 10, Iss. 7, pp. 646-651
Closed Access | Times Cited: 41
Hernán Alcaíno, Douglas Greig, Mario Chiong, et al.
European Journal of Heart Failure (2008) Vol. 10, Iss. 7, pp. 646-651
Closed Access | Times Cited: 41
The Role of Uric Acid in Pediatric Hypertension
Daniel I. Feig, Richard J. Johnson
Journal of Renal Nutrition (2007) Vol. 17, Iss. 1, pp. 79-83
Open Access | Times Cited: 40
Daniel I. Feig, Richard J. Johnson
Journal of Renal Nutrition (2007) Vol. 17, Iss. 1, pp. 79-83
Open Access | Times Cited: 40
Allopurinol for Secondary Prevention in Patients with Cardiovascular Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Yuyang Ye, Guangzhi Liao, Ting Liu, et al.
Journal of Cardiovascular Development and Disease (2023) Vol. 10, Iss. 9, pp. 379-379
Open Access | Times Cited: 7
Yuyang Ye, Guangzhi Liao, Ting Liu, et al.
Journal of Cardiovascular Development and Disease (2023) Vol. 10, Iss. 9, pp. 379-379
Open Access | Times Cited: 7
Clinical trials update from the Heart Failure Society of America meeting: FIX‐CHF‐4, selective cardiac myosin activator and OPT‐CHF
John G.F. Cleland, A Coletta, Andrew L. Clark
European Journal of Heart Failure (2006) Vol. 8, Iss. 7, pp. 764-766
Closed Access | Times Cited: 37
John G.F. Cleland, A Coletta, Andrew L. Clark
European Journal of Heart Failure (2006) Vol. 8, Iss. 7, pp. 764-766
Closed Access | Times Cited: 37
Serum Uric Acid level in the severity of Congestive Heart Failure (CHF)
Adnan Khan, Mohammad Hassan Shah, Sarbiland Khan, et al.
Pakistan Journal of Medical Sciences (2017) Vol. 33, Iss. 2
Open Access | Times Cited: 23
Adnan Khan, Mohammad Hassan Shah, Sarbiland Khan, et al.
Pakistan Journal of Medical Sciences (2017) Vol. 33, Iss. 2
Open Access | Times Cited: 23
The pharmacologic spectrum of furosemide
Lisa Abbott, Jan P. Kovacic
Journal of Veterinary Emergency and Critical Care (2008) Vol. 18, Iss. 1, pp. 26-39
Open Access | Times Cited: 22
Lisa Abbott, Jan P. Kovacic
Journal of Veterinary Emergency and Critical Care (2008) Vol. 18, Iss. 1, pp. 26-39
Open Access | Times Cited: 22
Ácido úrico: una molécula con acciones paradójicas en la insuficiencia cardiaca
Hernán Alcaíno, Douglas Greig, Pablo Castro, et al.
Revista médica de Chile (2011) Vol. 139, Iss. 4, pp. 505-515
Open Access | Times Cited: 16
Hernán Alcaíno, Douglas Greig, Pablo Castro, et al.
Revista médica de Chile (2011) Vol. 139, Iss. 4, pp. 505-515
Open Access | Times Cited: 16
The Impact of Health Resort Treatment on the Nonenzymatic Endogenous Antioxidant System
Jadwiga Kuciel−Lewandowska, Michał Kasperczak, Bożena Bogut, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-9
Open Access | Times Cited: 13
Jadwiga Kuciel−Lewandowska, Michał Kasperczak, Bożena Bogut, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-9
Open Access | Times Cited: 13
